ArticleNucleic acids research2026
A multivalent RNA affinity tag enables selective purification of tagged RNAs and bound proteins.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Efficient purification of specific RNAs from lysates remains a major challenge. Existing methods, such as MS2 tagging or oligonucleotide hybridization, require protein immobilization or sequence-specific hybridization, limiting scalability and compatibility with diverse RNAs. Current approaches often have low recovery, exhibit slow kinetics, and generate background contamination, limiting their use in RNA-protein interaction studies. To overcome these limitations, we developed FS2, an RNA sequence that binds Sephadex beads with high affinity, thus acting as an affinity tag for protein-free, rapid, and simple RNA purification. FS2 consists of two copies of the dextran-binding D8 aptamer embedded within the highly stable F30 three-way junction RNA scaffold, which promotes aptamer folding and enhances avidity. Systematic optimization revealed that FS2 exhibits rapid binding kinetics, efficient purification, and efficient elution under mild conditions (50°C, 10 mM EDTA), representing substantial improvements over existing RNA purification systems. We validated the utility of FS2 by purifying an FS2-tagged MYC mRNA fragment from HEK293T cells and demonstrating that N6-methyladenosine (m6A)-containing mRNAs can be pulled down along with the m6A-binding protein YTHDF2. Overall, FS2 provides a highly simple and efficient RNA-based affinity tag for recovering RNA from complex mixtures and lysates for diverse applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.